Skip to main content

Rheumatoid Arthritis

      RT @drdavidliew: VTE/VZV in baricitinib & tofacitinib seem unrelated to on-target effects.

      Is there VTE/VZV-related
      3 years 10 months ago
      VTE/VZV in baricitinib & tofacitinib seem unrelated to on-target effects. Is there VTE/VZV-related off-target culpable binding? Computer (AI) says no, but... bari binds PDE10A2 (an antipsychotic target), lab confirmed. Missing link to reduced pain? POS0091 #EULAR2021 @RheumNow https://t.co/uqYixHhW1z
      RT @drdavidliew: Each line is a different country's JAK inhibitor for RA registry, looking at drug stopped for adverse e
      3 years 10 months ago
      Each line is a different country's JAK inhibitor for RA registry, looking at drug stopped for adverse events. Why all the variation? (Until we sort that out, we'll struggle to assess JAKi post-marketing safety...) @k_lauper's JAK-pot study POS0093 #EULAR2021 @RheumNow https://t.co/YykoG7LlEw
      RT @Stiddyo: #OP0089 Do you know the pain catastrophizing score #PCS ? Cross-sectional study of 1199 #RA, #PsA & #a
      3 years 10 months ago
      #OP0089 Do you know the pain catastrophizing score #PCS ? Cross-sectional study of 1199 #RA, #PsA & #ax-SpA patients: Low PCS were more often in remission as high PCS in RA & ax-SpA. PCS was associated with remission rates in RA and ax-SpA, but not in PsA #EULAR2021 @RheumNow https://t.co/MYiLmPPbDN
      RT @MeralElRamahiMD: #EULAR2021: Reduced likelihood of reaching disease remission in patients with RA or PsA who have co
      3 years 10 months ago
      #EULAR2021: Reduced likelihood of reaching disease remission in patients with RA or PsA who have concomitant depression and anxiety per prospective NOR-DMARD study. Social state and mental health factors play an important role in noresponse in T2T approach. @RheumNow https://t.co/Vl0Xkz2SNF
      RT @Stiddyo: Using data of the E3N prospective observational study - including 98995 women - passive smoking in childhoo
      3 years 10 months ago
      Using data of the E3N prospective observational study - including 98995 women - passive smoking in childhood or adulthood could be found as risk factor for #RA and potentially earlier onset #OP0012 #EULAR2021 @RheumNow https://t.co/58DJ8lZzfV
      RT @Stiddyo: Novel Results from the @rheum_covid register in #RA patients presented by @jeffsparks #OP0006
      Higher risk f
      3 years 10 months ago
      Novel Results from the @rheum_covid register in #RA patients presented by @jeffsparks #OP0006 Higher risk for patients on rituximab or on JAK inhibitors for hospitalisation & ventilation or death after #COVID19 infection compared to TNFi users. #EULAR2021 @RheumNow https://t.co/40h5zVpxAO
      RT @AurelieRheumo: Data from E3N-EPIC cohort: passive tabagism in both childhood (HR 1.42 95CI [1.07 to 1.88]) and adult
      3 years 10 months ago
      Data from E3N-EPIC cohort: passive tabagism in both childhood (HR 1.42 95CI [1.07 to 1.88]) and adulthood (HR 1.27 95CI [1.02 to 1.57]) associated with higher risk of RA in non smoking women (adjusted on age passive smoking educational level BMI) #EULAR2021 @RheumNow #OP0012
      RT @AurelieRheumo: Towards personalized therapy in RA with @MeganHanlon4's work: the synovial macrophage sub-population
      3 years 10 months ago
      Towards personalized therapy in RA with @MeganHanlon4's work: the synovial macrophage sub-population CD206+CD163+ is significantly enriched in RA synovial tissue, correlated with disease activity and baseline levels predict response to therapy. #EULAR2021 @RheumNow #OP0028
      RT @AurelieRheumo: Insights in RA and colon:
      Naïve RA patients
      -higher degree of intestinal permeability vs age and s
      3 years 10 months ago
      Insights in RA and colon: Naïve RA patients -higher degree of intestinal permeability vs age and sex matched ctrls in colonic biopsies -higher serum levels of bacterial translocation markers (LBP and CD14s); reduced in resp to DMARDs. #EULAR2021 @RheumNow #OP0035 @ClaireDaien
      ×